Anti-CRISPR: Discovery, mechanism and function

Nature Reviews Microbiology

Volumn 16, Issue 1, 2018, Pages 12-17

  Pawluk, April ^a   Davidson, Alan R ^b   Maxwell, Karen L ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CRISPR ASSOCIATED PROTEIN; CRISPR ASSOCIATED PROTEIN ANTIBODY; CRISPR CAS INHIBITOR; PROTEIN INHIBITOR; UNCLASSIFIED DRUG; PROTEIN BINDING; VIRAL PROTEIN;

ADAPTIVE IMMUNITY; ARTICLE; BIOTECHNOLOGY; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; CRISPR CAS SYSTEM; GENE TRANSFER; MOLECULAR EVOLUTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; TOXIN-ANTITOXIN SYSTEM; BACTERIAL PHENOMENA AND FUNCTIONS; BACTERIOPHAGE; BACTERIUM; EVOLUTION; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; VIROLOGY;

BACTERIA; BACTERIAL PHYSIOLOGICAL PHENOMENA; BACTERIOPHAGES; BIOLOGICAL EVOLUTION; BIOTECHNOLOGY; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS; CRISPR-CAS SYSTEMS; EVOLUTION, MOLECULAR; HOST-PATHOGEN INTERACTIONS; PROTEIN BINDING; VIRAL PROTEINS;

EID: 85038241811     PISSN: 17401526     EISSN: 17401534     Source Type: Journal    
DOI: 10.1038/nrmicro.2017.120     Document Type: Article

References (54)

1. Van Valen, L. A new evolutionary law. Evol. Theory 1, 1-30 (1973).
2. Kruger, D. H. & Bickle, T. A. Bacteriophage survival: multiple mechanisms for avoiding the deoxyribonucleic acid restriction systems of their hosts. Microbiol. Rev. 47, 345-360 (1983).
3. Drozdz, M., Piekarowicz, A., Bujnicki, J. M. & Radlinska, M. Novel non-specific DNA adenine methyltransferases. Nucleic Acids Res. 40, 2119-2130 (2012).
4. Kahmann, R. The mom gene of bacteriophage Mu. Curr. Top. Microbiol. Immunol. 108, 29-47 (1984).
5. Studier, F. W. & Movva, N. R. SAMase gene of bacteriophage T3 is responsible for overcoming host restriction. J. Virol. 19, 136-145 (1976).
6. Otsuka, Y. & Yonesaki, T. Dmd of bacteriophage T4 functions as an antitoxin against Escherichia coli LsoA and RnlA toxins. Mol. Microbiol. 83, 669-681 (2012).
7. Blower, T. R., Evans, T. J., Przybilski, R., Fineran, P. C. & Salmond, G. P. Viral evasion of a bacterial suicide system by RNA-based molecular mimicry enables infectious altruism. PLoS Genet. 8, e1003023 (2012).
8. Bondy-Denomy, J., Pawluk, A., Maxwell, K. L. & Davidson, A. R. Bacteriophage genes that inactivate the CRISPR/Cas bacterial immune system. Nature 493, 429-432 (2013).
9. Pawluk, A. et al. Naturally occurring off-switches for CRISPR Cas9. Cell 167, 1829-1838., 9 (2016).
10. Pawluk, A., Bondy-Denomy, J., Cheung, V. H., Maxwell, K. L. & Davidson, A. R. A new group of phage anti-CRISPR genes inhibits the type I E CRISPR-Cas system of Pseudomonas aeruginosa. mBio 5, e00896 (2014).
11. Pawluk, A. et al. Inactivation of CRISPR-Cas systems by anti-CRISPR proteins in diverse bacterial species. Nat. Microbiol. 1, 16085 (2016).
12. Rauch, B. J. et al. Inhibition of CRISPR Cas9 with bacteriophage proteins. Cell 168, 150-158., 10 (2017).
13. Hynes, A. P. et al. An anti-CRISPR from a virulent streptococcal phage inhibits Streptococcus pyogenesCas9. Nat. Microbiol. http://dx.doi.org/10.1038/s41564-017-0004-7 (2017).
14. Samson, J. E., Magadan, A. H., Sabri, M. & Moineau, S. Revenge of the phages: defeating bacterial defences. Nat. Rev. Microbiol. 11, 675-687 (2013).
15. Garneau, J. E. et al. The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA. Nature 468, 67-71 (2010).
16. Marraffini, L. A. & Sontheimer, E. J. CRISPR interference limits horizontal gene transfer in staphylococci by targeting DNA. Science 322, 1843-1845 (2008).
17. Barrangou, R. et al. CRISPR provides acquired resistance against viruses in prokaryotes. Science 315, 1709-1712 (2007).
18. Edgar, R. & Qimron, U. The Escherichia coli CRISPR system protects from λ lysogenization, lysogens, and prophage induction. J. Bacteriol. 192, 6291-6294 (2010).
19. Brouns, S. J. et al. Small CRISPR RNAs guide antiviral defense in prokaryotes. Science 321, 960-964 (2008).
20. Marraffini, L. A. CRISPR-Cas immunity in prokaryotes. Nature 526, 55-61 (2015).
21. Mohanraju, P. et al. Diverse evolutionary roots and mechanistic variations of the CRISPR-Cas systems. Science 353, aad5147 (2016).
22. Wright, A. V., Nunez, J. K. & Doudna, J. A. Biology and applications of CRISPR systems: harnessing nature's toolbox for genome engineering. Cell 164, 29-44 (2016).
23. Makarova, K. S. et al. An updated evolutionary classification of CRISPR-Cas systems. Nat. Rev. Microbiol. 13, 722-736 (2015).
24. Koonin, E. V., Makarova, K. S. & Zhang, F. Diversity, classification and evolution of CRISPR-Cas systems. Curr. Opin. Microbiol. 37, 67-78 (2017).
25. Wang, H., La Russa, M. & Qi, L. S. CRISPR/Cas9 in genome editing and beyond. Annu. Rev. Biochem. 85, 227-264 (2016).
26. Bikard, D., Hatoum-Aslan, A., Mucida, D. & Marraffini, L. A. CRISPR interference can prevent natural transformation and virulence acquisition during in vivo bacterial infection. Cell Host Microbe 12, 177-186 (2012).
27. Wozniak, R. A. & Waldor, M. K. Integrative and conjugative elements: mosaic mobile genetic elements enabling dynamic lateral gene flow. Nat. Rev. Microbiol. 8, 552-563 (2010).
28. Dobrindt, U., Hochhut, B., Hentschel, U. & Hacker, J. Genomic islands in pathogenic and environmental microorganisms. Nat. Rev. Microbiol. 2, 414-424 (2004).
29. Juhas, M. et al. Genomic islands: Tools of bacterial horizontal gene transfer and evolution. FEMS Microbiol. Rev. 33, 376-393 (2009).
30. Sun, C. L. et al. Phage mutations in response to CRISPR diversification in a bacterial population. Environ. Microbiol. 15, 463-470 (2013).
31. van Houte, S. et al. The diversity-generating benefits of a prokaryotic adaptive immune system. Nature 532, 385-388 (2016).
32. Fineran, P. C. et al. Degenerate target sites mediate rapid primed CRISPR adaptation. Proc. Natl Acad. Sci. USA 111, E1629-E1638 (2014).
33. Gophna, U. et al. No evidence of inhibition of horizontal gene transfer by CRISPR-Cas on evolutionary timescales. ISME J. 9, 2021-2027 (2015).
34. Touchon, M., Bernheim, A. & Rocha, E. P. Genetic and life-history traits associated with the distribution of prophages in bacteria. ISME J. 10, 2744-2754 (2016).
35. Touchon, M. et al. Antibiotic resistance plasmids spread among natural isolates of Escherichia coli in spite of CRISPR elements. Microbiology 158, 2997-3004 (2012).
36. Dang, T. N. et al. Uropathogenic Escherichia coli are less likely than paired fecal E. coli to have CRISPR loci. Infect. Genet. Evol. 19, 212-218 (2013).
37. Bondy-Denomy, J. et al. Multiple mechanisms for CRISPR-Cas inhibition by anti-CRISPR proteins. Nature 526, 136-139 (2015).
38. Chowdhury, S. et al. Structure reveals mechanisms of viral suppressors that intercept a CRISPR RNA-guided surveillance complex. Cell 169, 47-57, 11 (2017).
39. Peng, R. et al. Alternate binding modes of anti-CRISPR viral suppressors AcrF1/2 to Csy surveillance complex revealed by cryo-EM structures. Cell Res. 27, 853-864 (2017).
40. Maxwell, K. L. et al. The solution structure of an anti- CRISPR protein. Nat. Commun. 7, 13134 (2016).
41. van Erp, P. B. et al. Mechanism of CRISPR-RNA guided recognition of DNA targets in Escherichia coli. Nucleic Acids Res. 43, 8381-8391 (2015).
42. Dong, D. et al. Structural basis of CRISPR SpyCas9 inhibition by an anti-CRISPR protein. Nature 546, 436-439 (2017).
43. Yang, H. & Patel, D. J. Inhibition mechanism of an anti-CRISPR suppressor AcrIIA4 targeting SpyCas9. Mol. Cell 67, 117-127. 5 (2017).
44. Shin, J. et al. Disabling Cas9 by an anti-CRISPR DNA mimic. Sci. Adv. 3, e1701620 (2017).
45. Harrington, L. B. et al. A broad-spectrum inhibitor of CRISPR Cas9. Cell 170, 1224-1233., 15 (2017).
46. Wang, X. et al. Structural basis of Cas3 inhibition by the bacteriophage protein AcrF3. Nat. Struct. Mol. Biol. 23, 868-870 (2016).
47. Wang, J. et al. A CRISPR evolutionary arms race: structural insights into viral anti-CRISPR/Cas responses. Cell Res. 26, 1165-1168 (2016).
48. Burstein, D. et al. Major bacterial lineages are essentially devoid of CRISPR-Cas viral defence systems. Nat. Commun. 7, 10613 (2016).
49. Jiang, W. et al. Dealing with the evolutionary downside of CRISPR immunity: bacteria and beneficial plasmids. PLoS Genet. 9, e1003844 (2013).
50. Westra, E. R. et al. Parasite exposure drives selective evolution of constitutive versus inducible defense. Curr. Biol. 25, 1043-1049 (2015).
51. Gilbert, L. A. et al. CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell 154, 442-451 (2013).
52. Dominguez, A. A., Lim, W. A. & Qi, L. S. Beyond editing: Repurposing CRISPR Cas9 for precision genome regulation and interrogation. Nat. Rev. Mol. Cell Biol. 17, 5-15 (2016).
53. Maxwell, K. L. Phages fight back: inactivation of the CRISPR-Cas bacterial immune system by anti-CRISPR proteins. PLoS Pathog. 12, e1005282 (2016).
54. Hug, L. A. et al. A new view of the tree of life. Nat. Microbiol. 1, 16048 (2016).